Global Defibrillators Market Analysis: Devices, End Users and Forecast to 2020, New Findings by iHealthcareAnalyst, Inc.

Defibrillators Market by Product Type (Advanced Life Support Defibrillators, Automated External Defibrillators, Implantable Cardioverter Defibrillators, Wearable Defibrillators) and End Users (Business Workplace, Emergency Medical Services, Homes, Hospitals, Public Access Defibrillation) 2016-2020.

Maryland Heights, MO, February 10, 2017 --(PR.com)-- The global defibrillators market is estimated to reach USD 15.4 Billion in 2020, expanding at a CAGR of 6.6% from 2016 to 2020, due to increasing cardiovascular disorders and advanced technology adoption worldwide. At present, with the advanced versions of defibrillators such as implantable cardioverter defibrillators (ICD), wearable defibrillators and automated external defibrillators the survival rate of patients in out-of-home settings have improved significantly across the globe.

Browse Defibrillators Market by Product Type (Advanced Life Support Defibrillators, Automated External Defibrillators, Implantable Cardioverter Defibrillators, Wearable Defibrillators) and End Users (Business Workplace, Emergency Medical Services, Homes, Hospitals, Public Access Defibrillation) 2016-2020 at https://www.ihealthcareanalyst.com/report/defibrillators-market/.

Defibrillation consists of delivering a therapeutic dose of electrical current to the heart with a device called a defibrillator. This depolarizes a critical mass of the heart muscle, terminates the dysrhythmia and allows normal sinus rhythm to be reestablished by the body's natural pacemaker, in the sinoatrial node of the heart. Defibrillation is a common treatment for life-threatening cardiac dysrhythmias and ventricular fibrillation. Defibrillators can be external, transvenous, or implanted (implantable cardioverter-defibrillator), depending on the type of device used or needed. Some external units, known as automated external defibrillators (AEDs) are used to automate the diagnosis of treatable rhythms.

The global defibrillators market segmentation is based on product types (Advanced Life Support (ALS) Defibrillators, Automated External Defibrillators (AEDs), Implantable Cardioverter Defibrillators (ICD), Wearable Defibrillators) and end users (business workplace, emergency medical services, homes, hospitals, public access defibrillation).

The global defibrillators market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020). The global defibrillators market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global defibrillators market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major players operating in the global defibrillators market and included in this report are Biotronik SE & Co. KG, Defibtech, LLC, GE Healthcare, Heartsine Technologies, Inc., Nihon Kohden Corporation, Physio-Control, Inc., St. Jude Medical Inc., Philips Healthcare and others.

To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/defibrillators-market/

About Us
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: https://www.ihealthcareanalyst.com
Contact
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 500-7508
https://www.ihealthcareanalyst.com/
ContactContact
Categories